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Abstract Investigation of magainin II amide analogs with
cationic charges ranging between +3 and +7 showed that
enhancement of the peptide charge up to a threshold value of
+5 and conservation of appropriate hydrophobic properties
optimized the antimicrobial activity and selectivity. High
selectivity was the result of both enhanced antimicrobial and
reduced hemolytic activity. Charge increase beyond +5 with
retention of other structural motifs led to a dramatic increase of
hemolytic activity and loss of antimicrobial selectivity. Selectiv-
ity could be restored by reduction of the hydrophobicity of the
hydrophobic helix surface (Hhd), a structural parameter not
previously considered to modulate activity. Dye release experi-
ments with lipid vesicles revealed that the potential of peptide
charge to modulate membrane activity is limited: on highly
negatively charged 1-palmitoyl-2-oleoylphosphatidyl-DL-glycerol
bilayers, reinforcement of electrostatic interactions had an
activity-reducing effect. On neutral 1-palmitoyl-2-oleoylphos-
phatidylcholine bilayers, the high activity was determined by
Hhd. Hhd values above a certain threshold led to effective
permeabilization of all lipid systems and even compensated for
the activity-reducing effect of charge increase on highly
negatively charged membranes. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Magainin II amide (MIIa, GIGKF LHSAK KFGKA
FVGEI MNS HN2) and related peptides are potent antimi-
crobial compounds with a broad spectrum of activity [1].
Their e¡ect is the result of a direct interaction with the lipid
matrix of the target membrane leading to the disturbance of
its barrier function. In the ¢rst stage of the permeabilization
process peptides bind to the cell surface. The second step
involves insertion into and destabilization of the membrane.
A number of studies have shown that magainins might be
good candidates for therapeutic agents [2]. Therefore, consid-
erable e¡ort has been focussed on optimizing peptide^lipid
interactions to improve antimicrobial activity and selectivity
[3,4]. For both recognition and permeabilization of the bacte-
rial membrane, electrostatic attraction between the cationic
peptides and the negatively charged cell surface plays an im-
portant role. The enhancement of the total cationic peptide
charge often resulted in higher antimicrobial activity [4^7]
attributed to increased a⁄nity for the bacterial membrane.
However, a higher number of positive groups does not always
increase the activity, suggesting a more complex interaction.
In model peptides enhancement as well as reduction of charge
led to analogs with improved antimicrobial activity [8]. Other
studies showed that highly cationic peptides may even be de-
void of antimicrobial activity [9]. One reason for our inability
to predict reliably the in£uence of charge modi¢cation on
antimicrobial and hemolytic activity is the fact that amino
acid substitutions result in variation of certain structural pa-
rameters which in£uence peptide activity. Thus, changes in the
position of charged residues may in£uence helicity (K) and the
hydrophobic moment (W) (see e.g. [8]) and an increase in the
number of charges (Q) is always connected with reduced pep-
tide hydrophobicity (H) and a modi¢cation of W [9].
Studies of structural parameters characterizing an amphi-
pathic helix led us to suggest that peptide^membrane interac-
tion is determined by a sensitive balance of hydrophobic and
electrostatic interactions [4,10]. In this study the in£uence of
peptide charge on membrane activity and selectivity was an-
alyzed. Following our strategy of systematic variation of only
one parameter while conserving all other structural motifs
[11], peptides of modi¢ed charge were synthesized and struc-
turally characterized. Their antimicrobial and hemolytic activ-
ities were examined. Studies on model membranes were per-
formed, addressing the question of how peptide charge
modulates the two determinants of the permeabilization pro-
cess : a⁄nity and permeabilizing e⁄ciency. The data indicate
that increase of Q, conservation of moderate H and an ap-
propriate W render magainin more active and selective for
bacterial cells. However, there was a threshold value for opti-
mized electrostatic interactions. Additionally, the hydropho-
bicity of the non-cationic helix surface (Hhd) has been recog-
nized as an activity- and selectivity-modifying property.
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2. Materials and methods
2.1. Materials
The lipids 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and 1-
palmitoyl-2-oleoylphosphatidyl-DL-glycerol (POPG) were purchased
from Avanti Polar Lipids (Alabaster, AL, USA). 9-Fluorenylme-
thoxy-carbonyl (Fmoc) amino acids were obtained from Novabio-
chem (Bad Soden, Germany). All other chemicals were of analytical
or reagent grade. Peptides were synthesized by automated solid-phase
methods using standard Fmoc chemistry on a MilliGen 9050 (Milli-
pore, Bedford, MA, USA) peptide synthesizer [12]. Puri¢cation by
preparative high performance liquid chromatography (HPLC) gave
¢nal products s 95% pure by HPLC analysis. The peptides were
characterized by mass spectrometry (MALDI II; Kratos, Manchester,
UK) and quantitative amino acid analysis (LC 3000, Biotronik, Ep-
pendorf, Germany).
2.2. Vesicle preparation
Small unilamellar vesicles (SUVs; about 40 mM lipid in 10 mM
tris(hydroxymethyl)aminomethane (Tris) bu¡er containing 154 mM
NaF and 0.1 mM ethylenediaminetetraacetic acid (EDTA), pH 7.4)
were prepared by sonication and characterized as described [10]. Dye-
containing large unilamellar vesicles (LUVs) were prepared by the
extrusion of the vortexed lipid suspensions (70 mM calcein, 10 mM
Tris, 0.1 mM EDTA, pH 7.4) through polycarbonate ¢lters (six times
through two stacked 0.4 Wm pore size ¢lters followed by eight times
through two stacked 0.1 Wm pore size ¢lters) [10]. Untrapped dye was
removed from the LUVs by microcolumn centrifugation on Sephadex
G50 according to the procedure described by New [13]. Lipid concen-
tration was determined by phosphorus analysis [14].
2.3. Circular dichroism (CD) measurements and dye release
CD measurements were carried out on a Jasco 720 spectrometer as
described elsewhere [10]. The K of the peptides was determined from
the mean residue ellipticity (3) at 222 nm [15]. All data are the means
of two independent measurements which did not deviate by more than
5%.
Calcein release from vesicles was determined by measuring the de-
crease in self-quenching 1 min after injecting an aliquot of dye-con-
taining vesicular suspensions into a cuvette containing stirred peptide
solutions (10 mM Tris, 154 mM NaCl, 0.1 mM EDTA, pH 7.4)
(excitation at 490 nm, emission at 520 nm) on a Perkin-Elmer LS
50B spectro£uorometer [9]. The £uorescence intensity corresponding
to 100% release was determined by addition of Triton X-100 (10% v/v
in water). Peptide concentration causing 50% dye e¥ux (EC50) was
estimated from dose^response curves.
Apparent binding constants for peptide^lipid interaction were de-
termined from binding isotherms evaluated from the change of the
peptide CD according to the procedure described by Schwarz and
Beschiaschvili [16]. Binding isotherms from calcein-releasing experi-
ments were derived according to Matsuzaki et al. [17].
2.4. Biological activity
Hemolytic activity was determined using human red blood cells
(Blutspendedienst des DRK, Berlin, Germany) by measuring the pep-
tide-induced changes of the optical density (OD) at 540 nm (Lambda
9, Perkin-Elmer, Germany) [10]. Peptide concentrations causing 50%
hemolysis (EC50) were derived from dose^response curves. Values
from repeat experiments di¡ered by less than 5%.
Escherichia coli (DH5K strain) and Bacillus subtilis (PY 22 strain)
cultivated in Luria broth (Gibco BRL, Paisley, UK) were used to test
the antibacterial activity of the peptides. The inoculum was prepared
from mid-logarithmic phase cultures (OD600 = 0.5). Aliquots of cell
suspension were added to the wells of a microtiter plate containing
peptide solutions of di¡erent concentrations. The ¢nal density of bac-
teria in the wells was 1.25U106 CFU/ml. The peptide concentration
ranged from 0.04 to 80 WM in two-fold dilutions. All peptides were
tested in duplicate. After incubation overnight at 37‡C with gentle
shaking, the absorbance was read at 600 nm (Autoreader EL 311,
Bio-Tek Instruments, USA). The minimum inhibitory concentration
(MIC) is de¢ned as the lowest concentration of peptide at which there
was no change in OD.
3. Results
3.1. Peptide design and structural characterization
MIIa peptides of modi¢ed cationic charge (Q) were de-
signed following our strategy of keeping all other structural
motifs, such as K, H, W and P, largely constant (Fig. 1, Table
1). The set is based on an analog with high antimicrobial and
moderate hemolytic activity which di¡ers from MIIa by an
enhanced W [4]. The peptides (+39Q9+7) were prepared by
variation of the number of lysine residues. Modi¢cation of the
negative charge was avoided because of E19 exchange [6] and
a negatively charged C-terminus [18] have been reported to
substantially reduce the stability of the magainin helix. Histi-
dine has been reported to be uncharged under physiological
pH conditions used in this study [19]. Changes of H and W
connected with the manipulation of charge were compensated
by the introduction of more hydrophobic residues and varia-
tion of the position of several amino acids (Fig. 1). These
modi¢cations resulted in changes of the Hhd (Table 1), a
Fig. 1. Helical wheel projection of charge-modi¢ed MIIa analogs. Q is given in the center of the wheel. The angle subtended by cationic resi-
dues (black circles) is P= 120‡. The 14 amino acid residues covering the angle of 240‡ were used for calculation of the mean residue Hhd.
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structural motif not considered so far as a potential activity-
modulating parameter. To assess the role of Hhd, an addition-
al analog (MEK6) characterized by six positive charges and
the Hhd of MK5E was prepared (Table 1). The increase of
charge from +5 to +6 and the conservation of Hhd, however,
resulted in reduced total H. The analog MK6 (N in position
19 and thus bearing seven positive charges) was included in
the studies to con¢rm the surprising results with MK6E char-
acterized by a pronounced Hhd.
All peptides showed pronounced K in 2,2,2-tri£uoroethanol
(TFE)/bu¡er (1/1 v/v) mixture (Table 1). The high K, exceed-
ing 86% for the two analogs MK6E and MK6 with an Hhd of
about 0.36, can be associated with the substitution of G13;18
by helix-promoting lysine residues [20]. The retention time
(tR) in RP-HPLC re£ecting a⁄nity to the hydrophobic sta-
tionary phase is closely related to the induced K of peptides
[21]. Table 1 shows that the tR of peptide with conserved H, W
was linearly related to the product of HhdUKTFE. Peptide K in
the lipid-bound state was determined using highly negatively
charged POPG and electrically neutral POPC vesicles (Table
1). Titration of peptide solutions with lipid suspensions
showed that constant ellipticity re£ecting complete binding
to POPG vesicles was reached at a peptide to lipid molar ratio
(cl/cp) as low as 15. Binding to neutral POPC liposomes re-
quired cl/cpv350 (data not shown). Although completely
bound (99.8%s bindings 97%), striking di¡erences in the K
of the peptides were observed. Hhd values higher than 0.326
distinctly favored helix formation. Additionally, a negative
surface charge of the vesicles inhibited helix formation in pep-
tides with Q6+6. Both observations point to the dominating
role of hydrophobic peptide^lipid interactions for the induc-
tion of the peptide helix [21].
3.2. Biological activity
The increase of peptide charge led to enhanced activity
against both Gram-positive and Gram-negative bacteria
which reached a maximum at a peptide charge of +5 (Fig.
2). The high antibacterial activity was retained on a charge
increase beyond +5. The MIC of MK6 against E. coli could
not be determined reliably. Reduction of OD was associated
with precipitation during the incubation time. The increase of
antimicrobial activity was accompanied by a substantial re-
duction of hemolytic activity (Fig. 2). MK5E was practically
inactive against red blood cells. Further charge increases for
peptides with conserved H, W and P to +6 and +7 (MK6E,
MK6) led to a striking increase of the undesired hemolytic
e¡ect. The low hemolytic activity of a six charges-bearing
peptide, however, could be restored in MEK6 by decreasing
Hhd. Compared to the unmodi¢ed MIIa, the antimicrobial
activity of the optimized MK5E was increased by a factor
of 50 and the selectivity was 20 times higher (Fig. 2).
3.3. Bilayer-permeabilizing activity
All peptides showed a high permeabilizing activity against
POPG, mixed POPG/POPC and POPC liposomes. However,
the activity pattern on the di¡erent lipid systems di¡ered (Fig.
3). The activity against POPG liposomes distinctly decreased
when increasing peptide charge from +3 to +5. MEK6 (+6
charge, Hhd 0.326) ¢ts this pro¢le. However, MK6E and MK6
showed substantially improved activity which is related to the
high K in the lipid-bound state and the elevated Hhd (Table 1,
Fig. 3). No relationship between peptide charge and activity
against POPC vesicles was found. The EC50 was rather related
to peptide K and Hhd. Peptide activity decreased upon enhanc-
ing the amount of negatively charged lipids in the vesicles
(Fig. 3). All peptides, except MK3E, were least active against
POPG vesicles, a phenomenon also observed for other pep-
tides [10].
Table 1
Structural properties of MIIa peptides bearing various charges
Peptide analog Q H W Hhd tR (min) K TFE KTFEUHhd K POPG (cl/cp = 50) K POPC (cl/cp = 520)
MK3E +3 30.0357 0.32 0.284 20.8 0.65 0.185 0.58 0.72
MK4E +4 30.0352 0.32 0.298 19.5 0.50 0.149 0.62 0.71
MK5E +5 30.0335 0.33 0.326 20.0 0.54 0.176 0.67 0.72
MK6E +6 30.0344 0.33 0.364 25.4 0.86 0.313 0.87 0.95
MK6 +7 30.0352 0.33 0.362 25.8 0.89 0.323 0.96 0.99
MEK6 +6 30.0922 0.35 0.326 18.4 0.67 0.218 0.77 0.78
Total Q, H, W, Hhd, HPLC tR and the amount of helix in structure inducing TFE/bu¡er (1/1 v/v) mixture (KTFE) and in the presence of nega-
tively charged POPG and electrically neutral POPC SUVs suspended in 10 mM Tris bu¡er containing 150 mM NaF, pH 7.4. The mean H was
calculated as the sum of the Hs of the individual amino acid residues divided by their number, W is the vector sum of the Hs and Hhd was de-
termined as the mean residue H of the 14 residues forming the non-cationic helix surface. The Eisenberg consensus scale of H was used [29]. K
was determined according to [20]. KTFEUHhd characterizes the hydrophobic helix surface. The peptide concentration was 1035 M. Because of
di¡ering a⁄nities, the ratio of lipid to peptide concentration (cl/cp) varied from 50 for POPG to 520 for POPC. For chromatographic details
see Section 2. MIIa is characterized by Q +4, H 30.0357, Hhd 0.289, W 0.29, P 120‡.
Fig. 2. The biological activity and selectivity of magainin peptides.
MIC of bacterial growth against E. coli (black bars) and B. subtilis
(gray bars) (1.25U106 CFU/ml) and concentration for half-maximal
lysis of red blood cells (white bars) (EC50) (2.3U108 cells/ml). The
values determined in two experiments di¡ered by less than 5%. The
MICs of MIIa were 40 WM (E. coli) and s 80 WM (B. subtilis), the
EC50 was 200 WM [6]. The prokaryotic speci¢city was determined as
the quotient of EC50 for human red blood cells and MIC of bacteri-
al growth (EC50/MIC).
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3.4. Binding and permeabilizing e⁄ciency
Apparent binding constants (Kapp) to the highly negatively
charged POPG LUVs were derived from dye release experi-
ments. This method is suitable if membrane binding correlates
directly with membrane leakage [22] : actually, cationic pep-
tide-induced permeabilization of highly negatively charged lip-
id bilayers is determined by the binding step [10]. Kapp of the
magainin analogs ranging between 50 000 M31 and 100 000
M31 re£ect their high a⁄nity to the POPG bilayer (Fig. 3).
Binding of MK3E, MK4E, MK5E and MEK6 to neutral
POPC SUVs is characterized by Kapp values in the range of
5000 and 15 000 M31 (Fig. 3). Distinctly increased a⁄nities of
MK6E and MK6 (Kapp = 20 000, 50 000 M31, respectively),
characterized by a pronounced Hhd, underline the dominance
of hydrophobic interactions. The standard free energy of mag-
ainin binding was almost identical for LUVs and SUVs [23].
The discrepancy between the slightly di¡erentiated EC50 of
the individual peptides for the permeabilization of POPC and
POPG vesicles and the pronounced di¡erences in their a⁄n-
ities to highly negatively charged and neutral bilayers (Fig. 3)
points to the important role of another regulatory step in the
permeabilization process ^ the ability of bound peptides to
disturb the lipid bilayer. The permeabilizing e⁄ciency is quan-
ti¢ed by the ratio of bound peptide per lipid (r) required to
induce 50% dye e¥ux. With about one to two peptide mole-
cules bound per 100 POPG molecules to induce dye release,
the r values show little variability and the permeabilizing e⁄-
ciency is very low (Fig. 3). On POPC bilayers, the e⁄ciency is
approximately 10 times higher. In both systems MK6E and
MK6 were the most e¡ective analogs. The results suggest that
besides a⁄nity, the permeabilizing e⁄ciency is also related to
peptide K and Hhd.
4. Discussion
Earlier studies had shown that K, H, W and P are e¡ective
modulators of antimicrobial activity but preferentially in£u-
ence the hemolytic e¡ect [4,11]. Thus, modi¢cation of these
parameters seemed less suitable for the generation of highly
active and highly selective antimicrobial peptides. This study
shows that one way of making MIIa peptides more antimi-
crobially active as well as selective is by reinforcement of
electrostatic peptide^membrane interaction by enhancement
of cationic peptide charge. The optimized activity of MK5E
is the result of both an improved antimicrobial e¡ect and a
drastically reduced hemolytic activity. However, the possibil-
ity of optimizing the antimicrobial e¡ect via modi¢cation of
peptide charge seems to be limited. Increase of Q beyond +5
may cause the loss of selectivity because reinforcement of the
hydrophobicity of the non-polar helix surface favors the he-
molytic e¡ect.
Structural studies of vesicle-bound peptides and the com-
parison of peptide activity on membranes of di¡erent surface
charges give information regarding the role of electrostatic
and hydrophobic interactions in the membrane permeabiliza-
tion process. All investigated peptides show high helicity upon
binding to lipid membranes (Table 1). Lipid-bound MIIa has
been found to be helical over the entire peptide chain. We
concluded that changes in K should be caused by modi¢cation
of the overall stability of the helix under the various condi-
tions [24]. Hydrophobic interactions between the peptides and
the environment have been reported to be the driving forces
for the induction and stabilization of a helical conformation
[21]. Thus, di¡erences in the helical content, coupled with
modi¢cation of peptide and bilayer surface charge, have to
be related to changes in the hydrophobic environment of
the peptides. In contrast to their conformational preferences
in aqueous solvent, the helical proclivity of amino acid resi-
dues such as glycine may be distinctly improved in membrane-
mimicking environments [21,25]. Additionally, for potentially
transmembrane model peptides, the induced K was found to
be related to the H of chain segments and the charge proper-
ties of lipid micelles [25]. The K of highly hydrophobic sequen-
ces was independent of the lipid head group charge. For less
hydrophobic sequences anionic lipids played a determining
role in helix formation. Comparable roles appear to be valid
for the amphipathic magainin peptides. However, inspection
of the structural parameters and K (Table 1) of MK5E and
MK6 (identical H but di¡erent Hhd) and MK5E and MEK6
(di¡erent H but identical Hhd) suggests that it is Hhd rather
than H which is important for helix induction. While an in-
crease of Hhd favors insertion into the acyl chain region of the
bilayers and helix formation, a negative bilayer charge inhibits
e¡ective hydrophobic peptide^lipid interactions. A value of
Hhd in the order of 0.36 appears to exist for this series of
peptides which, once exceeded, dictates that the peptide
adopts an almost complete helical conformation.
The a⁄nity of the investigated peptides to neutral POPC
bilayers (Fig. 3) was more than 10 times higher than that of
MIIa (Kapp = 400 M31) [24]. This enhanced binding is clearly
related to the well developed hydrophobic helix surfaces,
based on the high K and high Hhd. E¡ective disturbance of
the acyl chain region as a result of deep bilayer penetration
determines the high permeabilizing e⁄ciency of the peptides.
On mixed POPC/POPG bilayers activity-reducing electrostatic
Fig. 3. The lytic activity, a⁄nity and permeabilizing e⁄ciency of
magainin peptides. EC50 is the peptide concentration inducing 50%
dye release from LUVs composed of POPG (black bars), a mixture
of POPG/POPC (1/3 mol/mol) (gray bars) and POPC (white bars)
at a lipid concentration of 25 WM. Kapp is the apparent binding con-
stant determined CD-spectroscopically for the peptide interaction
with POPC vesicles, and by £uorescence spectroscopy from dye re-
lease experiments for POPG liposomes. r is the molar ratio of
bound peptide per lipid inducing 50% dye release and is taken as a
measure of the bilayer-permeabilizing e⁄ciency of the vesicle-bound
peptides.
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forces become e¡ective but the conserved activity pro¢le
points to the dominance of hydrophobic interactions. The
activity-reducing e¡ect of the electrostatic peptide^lipid inter-
action is much more pronounced on POPG bilayers. High,
barely di¡erentiated binding constants and comparably low
permeabilizing e⁄ciencies determine the e¡ect (Fig. 3). The
reduced activity of peptides with enhanced Q has to be asso-
ciated with the reduced permeabilizing e⁄ciency. Strong
charge interactions immobilize the cationic peptides in the
lipid head group region and thus inhibit insertion and mem-
brane disturbance [10,26]. A change in the balance of electro-
static versus hydrophobic interactions occurred with MK6E
and MK6. For these peptides the high K and Hhd values more
than compensate for the permeability-reducing e¡ect of in-
creased charge.
The discrepancy between the activity pro¢les of the peptides
studied against biological cells and lipid bilayers (Figs. 2 and
3) reveals the complex nature of peptide interaction with cell
membranes and underlines the limitations of model systems to
describe phenomena at the biological level. The derived mech-
anistic picture leads to the following interpretation of the bio-
logical data. On the slightly negatively charged membrane of
Gram-positive bacteria enhanced peptide accumulation based
on increased peptide charge and an appropriate permeabiliz-
ing e⁄ciency induced by the hydrophobic helix surface are
superimposed. Maximal activity is attained with ¢ve cationic
charges, indicating that the ionic peptide^membrane interac-
tion is optimized. Conservation of antibacterial activity with
extension of peptide charge beyond a threshold level has also
been reported for other magainin sequences [3].
With Gram-negative bacteria the outer lipopolysaccharide
membrane plays a strong activity-modulating role. Distur-
bance of the architecture of the outer wall in the rank order
of peptide charge [7] supports self-promoted peptide uptake
[27] and allows the peptides to reach and permeabilize the
inner target. However, reversible outer membrane permeabi-
lization seems to be limited. Peptides of high charge (e.g.
MK6) completely destroy the integrity of the outer wall.
The pronounced decrease in hemolytic activity
(MK3EsMK4EsMK5EsMEK6) points to electrostatic
interactions even for the red blood cell membrane which is
composed mainly of zwitterionic lipids. It is possible that
sialic acid molecules, located in the outer lea£et of the mem-
brane, may act to distance cationic peptides from the lipid
matrix [28] thus inhibiting membrane lysis. Decreasing hemo-
lytic activity with enhanced peptide charge has also been re-
ported for other magainin sequences [7].
In summary, an increase of charge has been found to im-
prove the antimicrobial activity of magainin peptides. The
high selectivity of the optimized MK5 analog is based on
both reinforcement of activity against bacteria and reduction
of the undesired hemolytic e¡ect underlining the therapeutic
potential of this analog.
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